Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells.
Yan ZhouShuchen LinKuo-Fu TsengKun HanYaling WangZhi-Hua GanDa-Liu MinHai-Yan HuPublished in: BMC cancer (2016)
MiR-302a targeted regulated the CUL1 expression and mediated the Selumetinib-induced cytotoxicity of triple-negative breast cancer.